Genes, Fibrinolysis and Endothelial Dysfunction- Dialysis Aim 3

Stopped early · Phase 3 · Has a placebo group

Conditions studied: Oxidative Stress, Endothelial Dysfunction

In brief

The purpose of the study is to see how two classes of blood pressure medications,angiotensin-converting enzyme inhibitors (Ace inhibitors) and angiotensin receptor blockers (ARBs), differ in their long term effects on certain chemicals in the body and on the carotid arteries.

Key facts

Study ID
NCT00878969
Run by
Vanderbilt University
People needed
78
Starts
2010-01-01
Expected to finish
2015-06-01
Last updated by the study team
2016-02-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.